Table 3 Tumor response to axitinib in combination with radiotherapy (n = 9)
| Â | Overall response | RT in-field response |
|---|---|---|
Complete response (CR) | 3 (33.3%) | 4 (44.4%) |
Partial response (PR) | 3 (33.3%) | 3 (33.3%) |
Stable disease (SD) | 0 (0%) | 0 (0%) |
Progressive disease (PD) | 3 (33.3%) | 2 (22.2%) |
Response rate (CR + PR) | 6 (66.7%) | 7 (77.8%) |